Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Keap 1: The New Janus Word on the Block

Version 1 : Received: 9 April 2022 / Approved: 11 April 2022 / Online: 11 April 2022 (10:39:31 CEST)

How to cite: Marcus, L.; Aye, Y. Keap 1: The New Janus Word on the Block. Preprints 2022, 2022040093 (doi: 10.20944/preprints202204.0093.v1). Marcus, L.; Aye, Y. Keap 1: The New Janus Word on the Block. Preprints 2022, 2022040093 (doi: 10.20944/preprints202204.0093.v1).

Abstract

Here we draw insights from the latest serendipitous findings made on the opposing roles of a validated drug-target protein Keap1. We weigh up how natural reactive electrophiles and electrophilic small-molecule drugs in clinical use directly impinge on seemingly conflicting, yet both Keap1-electrophile-modification-dependent, cell-survival- vs. cell-death-promoting behaviors. In the process, we convey how understanding reactive chemical-signal regulation at a single-protein-specific level is an enabling necessity in deconstructing otherwise intricate reactive-small-molecule-responsive cellular pathways. We hope this opinion piece further spurs the broader interests of basic and pharmaceutical research communities toward better understanding of molecular mechanisms underpinning reactive small-molecule-regulated signaling subsystems.

Keywords

Electrophile signaling; drug mechanism; immunology; antioxidant response; apoptosis

Subject

LIFE SCIENCES, Immunology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.

We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.